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Study of in vitro cytotoxicity and in vivo anti- tumour and anti-inflammatory activities of
Gmelina arborea Roxb. stem bark
                                                      INTRODUCTION
Inflammation can be defined as "a generalized and nonspecific but beneficial response of tissues
to injury". Inflammation was described as "the succession of changes which occurs in a living
tissue when it is injured provided that the injury is not of such a degree as to at once destroy its
structure and vitality", or "the reaction to injury of the living microcirculation and related tissues
(Spector et al., 1963). It comprises a complex array of adaptive responses to tissue injury which
are both local and systemic. 
      The local responses may result in recruitment of phagocytic cells and removal of endogenous
or  foreign  material.  The  systemic  responses  may  alter  the  ‘milieu  interior’ to  allow  these
processes to occur more efficiently (Denko et al., 1992, Henson; Murphy., 1989).
The  main  pathophysiological  pathways  for  drug  targeting  at  present  are:  arachidonic  acid
metabolism;  the  complement  cascade;  phagocytosis  and  other  cell  functions;  auto-immune
processes;  protein  kinase  C  and  others  enzymes  involved  in  second  messenger  systems
(Willianson, 1996). Early inflammation changes in damaged tissues are now known to involve in
the release of various biologically active materials from the polymorph nuclear leukocytes, the
lysosomal enzymes and others. In general, the vascular effects may primarily mediated by kinins,
prostaglandins and vaso-active amines (e.g. histamine, released by mast cells), which may cause
an increased vascular permeability leading to plasma exudation.
The inflammatory process  involves  a  complex interplay between the cells  of  blood,  and the
blood vessels themselves and also the cells of the tissue involved. The process can be seen as a
coordination response of a large number of cells to an initial stimulus. The immigrating cells
themselves  exert  little  effect  by  their  presence  alone,  but  it  can  initiate  the  entire  complex
reaction of inflammation as a consequence of the materials that they secrete or release to the
extra-cellular environment. Such materials include the molecules that exacerbate the responses
by attracting  the  inflammatory cells,  and  the  inhibitors  that  serve  to  reduce  the  severity  of
reactions, the histotoxic agents such as proteases, oxygen metabolites and cations, as well as
signals the surrounding inflammatory and tissue cells to implement some or all of the complex
reactions  which  they  are  capable  (Henson  et  al.,  1989).Uncontrolled  inflammation  is  an
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undesirable. The reversible features such as pain, redness, heat and swelling are joined by a fifth
and less transient feature namely, loss of function of the organs involved. Therefore the control
of inflammation is sought to protect the body function (Denko et al., 1992).
Causes
The  factors  that  can  stimulate  an  inflammation  include  microorganisms,  physical  agents,
chemical substances, inappropriate immunological responses and tissue death. Infectious agents
such as viruses and bacteria are some of the most common stimuli  of inflammation. Viruses
could give rise to inflammation by entering and destroying cells of the body; bacteria releases
substance  called  endotoxins  that  can  initiate  inflammation.  Inflammation  can  also  occur  by
physical trauma such  as  burns,  radiation,  and frostbite which can  damage  tissues,  and  by
corrosive  chemicals  such  as  acids,  alkalis,  and  oxidizing  agents.  As  mentioned  above,
malfunctioning  of  immunological  responses  can  incite  an  inappropriate  and  damaging
inflammatory response. Inflammation can also result when tissues die due to lack of oxygen and
nutrients, a situation that could often is caused by loss of blood flow to the area.
Signs
The  four  cardinal  signs  of  inflammation  are  redness, heat , swelling ,  and  pain.  These  were
mentioned in the 1st century AD by the Roman medical writer Aulus Cornelius Celsus. Redness
is caused by dilation of the small blood vessels at the site of injury. Heat results from increased
blood flow through the site and is experiences only in the peripheral parts of body such as skin.
Fever is also brought by chemical mediators of inflammation by rising the temperature at the
injury.  Swelling which is called as  edema is caused by the accumulation of fluid outside the
blood vessels.  The  pain accompanied  with  inflammation results  in  part  from the damage of
tissues caused by edema, and it is induced by certain chemical mediators of inflammation like
bradykinin, serotonin, and the prostaglandins.
A fifth effect  of inflammation is loss of function of  the inflamed area,  a  charecter noted by
German pathologist Rudolf Virchow in the 19th century. Loss of function results from pain that
inhibits movement or from severe swelling that prevents movement in the area. 
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The acute inflammatory response
Acute inflammation is the initial response of the body to harmful stimuli and is achieved by the
increased movement of plasma and leukocytes from the blood into the injured tissues. A series of
biochemical  events  is  propagated  and  matures  the  inflammatory  response,  involving  the
the immune system, local vascular system and various cells within the injured tissue. Prolonged
inflammation which is known as chronic inflammation, leads to a advancing shift in the type of
cells  present  at  the  area  of  inflammation  and  is  characterized  by  simultaneous  destruction
and healing of the tissue from the inflammatory process. 
Acute inflammation is a short term process, normally appearing within a few minutes or hours
and terminating upon the removal of the injurious stimulus.  The process of acute inflammation
is  initiated  by  cells  present  in  all  the  tissues  mainly  dendritic  cells, Kupffer  cells,
resident macrophages,  histocytes  and mastocytes.  These  cells  are  present  on  their  surfaces
contain  receptors  named pattern recognition receptors (PRRs),  and these  recognize molecules
that  are  shared  by pathogens but  distinguishable  from  host  molecules,  collectively  called
as pathogen-associated molecular patterns (PAMPs). At the beginning of an infection, injury or
burn,  these  cells  gets  activated  (one  of  their  PRRs  recognize  a  PAMP)  and   inflammatory
mediators are released  responsible for the clinical signs of inflammation. Vasodilation causes
increased blood flow which cause the redness and increased heat. The increased permeability of
the blood vessels  results  in exudation or leakage of plasma proteins and fluid into the tissue
which manifests itself as swelling. Some of the mediators released such as bradykinin increase
the sensitivity to pain which is reffered to hyperalgesia. The mediator molecules alters the blood
vessels to permit the migration of  neutrophils outside of the blood vessels into the tissue. The
neutrophils  migrate  along  a chemotactic gradient  created  by  local  cells  to  reach  the  site  of
injury. The loss  of  function (functio  laesa)  is  probably the result  of  a  neurological  reflex  in
response to pain.
In addition to cell-derived mediators various acellular biochemical cascade systems consisting of
plasma proteins acts in parallel to initiate and transmit the inflammatory response. These include
the complement  system ,  the coagulation and fibrinolysis  systems activated  by necrosis,  e.g.  a
burn  or  a  trauma.  The  acute  inflammatory  response  requires  constant  stimulation  to  be
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maintained. Inflammatory mediators have short half lives and are degraded quickly in the tissue.
Therefore, acute inflammation stops once the stimulus has been removed. 
Vascular changes
When tissue is first injured the small blood vessels in the damaged area constrict momentarily, a
process  called  vasoconstriction.  Following  this  temporary  event,  the  blood  vessels  dilate
(vasodilation), increasing blood flow into the site. Vasodilation may last from fifteen minutes to
several hours.
Next the walls of the blood vessels become more permeable, which allow only water and salts to
pass through easily. Protein-rich fluid called exudate, is able to exit into the tissues. Substances
in the exudate consists of clotting factors and these factors help prevent the spread of infectious
agents throughout the body. Other proteins are antibodies that help in destroying the invading
microorganisms.
As  the fluid  and  other  substances  leak  out  of  the  blood vessels,  blood flow becomes  more
inactive and white blood cells begin to fall out of the axial stream in the centre of the vessel to
flow near the vessel wall. The white blood cells then stick to the blood vessel wall which is the
first step in their emigration into the extravascular space of the tissue.
Cellular changes
The chief feature of inflammation is the accumulation of white blood cells at the site of injury.
Most of these cells are phagocytes, leukocytes that ingest bacteria and other foreign particles and
also  clean  up  cellular  debris  caused  by  injury.  The  main  phagocytes  engaged  in  acute
inflammation are the neutrophils which are, a type of white blood cell that contains granules of
enzymes destroying cells and proteins. When tissue damage is less, an adequate supply of these
cells can be acquired from those already circulating in the blood. When damage is more, some
immatured neutrophils are released from the bone marrow where they gets generated.
To perform the tasks, not only neutrophils must exit through the blood vessel wall but they must
actively move from the blood vessel toward the area of tissue damage. This movement is made
by chemical substances that diffuse from the site of tissue damage and create a concentration
gradient  followed  by   neutrophils.  The  substances  which  create  the  gradient  are  called
Chemotactic factors and the migration of cells along the gradient is called Chemotaxis. Large
numbers of neutrophils reach the site of injury first, sometimes within an hour after injury or
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infection. After the neutrophils, often 24 to 28 hours after inflammation begins, there comes
another  group of  white  blood cells,  the monocytes,  which eventually mature into cell-eating
macrophages. Macrophages usually become more prevalent at the site of injury only after days
or weeks and are a cellular hallmark of chronic inflammation.
Chemical mediators of inflammation
Although  injury  initiates  the  inflammatory  response,  chemical  factors  released  upon  this
stimulation  bring  about  the  vascular  and  cellular  changes  described  above.  The  chemicals
originate  from  white  blood  cells  (basophils,  neutrophils,  monocytes,  macrophages),
blood plasma,  platelets, mast cells, damaged tissue cells and endothelial cells lining the blood
vessels.  One of the best-known chemical  mediators  released from cells  during inflammation
is histamine which give rise  to  vasodilation and increases  vascular  permeability. Histamine is
released immediately stored in granules of circulating basophils and mast cells, when these cells
are injured.  Other  substances involving in the increased vascular  permeability are lysosomal
compounds released from neutrophils. The cytokines secreted by cells involved in inflammation
also contribute vasoactive and chemotactic properties.
The prostaglandins are a group of fatty acids produced by many types of cells in which some of
them  increase  the  effects  of  other  substances  that  promote  vascular  permeability.  Other
prostaglandins affect the aggregation of platelets which is the major part of the clotting process.
Prostaglandins are the cause or they are associated with the pain and fever of inflammation. Anti-
inflammatory drugs   such  as aspirin are  effective  in  this  because  they  inhibit  the
enzyme involved  in prostaglandin synthesis.  Prostaglandins  are  synthesized  from  arachidonic
acid,  as  are  the  leukotrienes,  another  group  of  chemical  mediators  that  have  vasoactive
properties.
The plasma contains  four  interrelated  systems  of  the kinins, proteins—complement,
coagulation factors and the fibrinolytic system, that generate various mediators of inflammation.
The activated complement proteins serve as chemotactic factors for neutrophils,, stimulate the
release of histamine from mast cells and increase vascular permeability They also adhere to the
surface of bacteria. This makes them easier targets for phagocytes. The kinin system is activated
by coagulation factor XII and produces substances that increase vascular permeability. The most
important of the kinins is bradykinin, which causes much of the pain and itching experienced
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with inflammation. The coagulation system converts the plasma protein fibrinogen into fibrin.
This  is  a  major  component  of  the  fluid  exudate.  The  fibrinolytic  system,  contributes  to
inflammation primarily through the formation of plasmin which breaks down fibrin into products
that affect vascular permeability.
Events following acute inflammation
Once acute inflammation has initiated, a number of events may follow. These include healing
and repair, suppuration,  and chronic inflammation. The events depends on the type of tissue
involved and the amount of tissue destroyed, which are in turn related to the cause of the injury.
Healing and Repair
During the healing process the damaged cells  which are capable of  proliferation regenerate.
Different types of cells varies from one another in their ability to regenerate. The cells such as
epithelial  cells  will  regenerate  easily,  while  other  cells  like  liver cells  does  not  normally
proliferate but can be stimulated to do so after damage has occurred. Various other types of cells
are incapable of regeneration. Repair, which occurs when tissue damage is substantial, results in
the formation of a fibrous scar. Through the repair process the endothelial cells gives rise to new
blood vessels, and cells called fibroblasts that grow to form a loose framework of connective
tissue. This delicate vascularized connective tissue is called granulation tissue. It derives its name
from the small red granular areas that are seen in healing tissue (e.g., the skin beneath a scab). 
Suppuration
The process of pus formation is called suppuration and it occurs when the agent that provoked
the inflammation cannot be eliminated. Pus is a viscous liquid that consists of dead and dying
neutrophils and bacteria, fluid leaked from blood vessels , and cellular debris. The most common
cause  of  suppuration  is  infection  with  the  pyogenic  or  pus-producing  bacteria  such
as Streptococcus and Staphylococcus.
Once pus begins to collect in a tissue, it becomes surrounded by a membrane and gives rise to a
structure  called  an abscess.  Because  an  abscess  is  virtually not  accessible  to  antibiotics  and
antibodies and its very difficult to treat and a surgical incision is needed to drain and eliminate it.
R.V.S College Of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 6 
Study of in vitro cytotoxicity and in vivo anti- tumour and anti-inflammatory activities of
Gmelina arborea Roxb. stem bark
Some abscesses such as boils will burst of their own. The abscess cavity then breaks down and
the tissue is replaced through the process of repair.
Chronic inflammation
If  an agent causing inflammation cannot be removed or if there is some hinderance with the
healing process, an acute inflammatory response may develop to the chronic stage. Repeated
occurrence  of  acute  inflammation also can  give  rise  to  chronic  inflammation.  The duration,
physical extent and the effects of chronic inflammation vary with the cause of the injury and the
body’s ability to improve the damage.
Some of the most common and disabling human diseases like rheumatoid arthritis, tuberculosis
and chronic lung disease are charecterized by this type of inflammation. Chronic inflammation
can be caused by infectious organisms that  are able to resist host  defences and continues in
tissues for an extended period. These organisms include protozoa, fungi, metazoal parasites and
Mycobacterium tuberculosis which is the  causative agent of tuberculosis.  Other inflammatory
causative agents are materials foreign to the body that cannot be removed by phagocytosis or
enzymatic breakdown such as  substances that can be inhaled like silica dust, metal that can enter
into wounds or wood splinters. In autoimmune reactions the stimulus to chronic inflammation is
a  normal  component  of  the  body  to  which  the immune  system has  become  sensitized.
Autoimmune reactions give rise to chronic inflammatory diseases such as rheumatoid arthritis.
The  indication  of  chronic  inflammation  is  the  infiltration  of  the  tissue  site
by plasma cells, lymphocytes,  and  macrophages  (mature antibody-producing B lymphocytes).
These  cells  are  taken  up  from the  circulation  by the  steady  release  of  chemotactic  factors.
Macrophages are the chief cells involved in chronic inflammation and produce many effects that
contribute  to  the  progression  of  tissue  damage  and  to  consequent  functional  impairment.
Granulomatous inflammation is a distinct type of chronic inflammation and is marked by the
formation of granulomas which are small collections of modified macrophages called epithelioid
cells  and  are  surrounded  by  lymphocytes.  Granulomas  contain,  cells  that  form  from  the
coalescence  of  epithelioid  cells  which  are  giant  or  Langhans.  A  definitive  example  of
granulomatous inflammation is tuberculosis, and the granulomas formed are called tubercles.
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Granulomas  also  typically  arise  from  fungal  infections,  and  they  are  present
in schistosomiasis, syphilis, and rheumatoid arthritis (Kara Rogers, 2009).
Types  of  Chronic  inflammation:  Unspecific  (e,g  :  chronic  peptic  ulcer)  and  specific
(granulomatous).According to the mechanism,  granulomatous inflammation may be:  immune
type (tuberculosis, sarcoidosis) and non-immune type (foreign body reaction).
 Classification of granulomatous inflammation based on the etiology:
1. Infectious granuloma:
                 1.  .Bacterial:
              a. Mycobacterium tuberculosis
              b. Mycobacterium leprae
              c. Treponema pallidum
              d. Gram-positive bacillus
              e. Gram-negative bacillus
                 2.   Parasitic
                        a.  Toxoplasma gondii- Toxoplasmosis
                        b.  Helminths- Cysticerosis
                 3.   Fungi
      11.  Foreign body granuloma
      111.  Unknown etiology granuloma :
                 1.   Sarcoidosis
                 2.   Crohn’ s disease
CANCER
Cancer  is  a  group of  diseases  which  is  characterized by uncontrolled growth and spread of
abnormal cells. If the spread of abnormal cells is uncontrolled it may lead to death. Cancer is
caused  by both  external  factors  like  tobacco,  chemicals,  radiation,  infectious  organisms  and
internal factors such as inherited mutations, immune conditions, hormones, and other mutations
that occur from metabolism. These causative factors may act either together or in sequence to
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initiate  or  promote  carcinogenesis.  Most  of  the  cancers  require  several  steps  for  their
development which occur over many years.
According  to  the  evaluation  from the  International  Agency for  Research  on  Cancer  (IARC)
(Ferlay et al., 2008), there were 12.7 million recent cancer cases in 2008 worldwide of which 7
million occurred in economically developing countries and 5.6 million occurred in economically
developed countries.
TUMOUR
A tumour is commonly used as a synonym for a neoplasm (Saunders., 2007). It is  a solid or fluid
filled cystic lesion that may or may not be formed by an abnormal growth of neoplastic cells that
appears enlarged in size. But tumor is not synonymous with cancer, cancer is malignant while a
tumor  can  be benign,  pre-malignant  or  malignant,  or  it  can  represent  a  lesion  without  any
cancerous potential.  Cancer stem cells may play an important role in tumor growth. Scientists
believes that cancer might have its own stem cells that results in the re growth of tumours. 
According to Medilexicon's medical dictionary ( Nordqvist et al., 2012), a Tumour is:
1.  Any swelling or tumefaction.
2. One of the four signs of inflammation enunciated by Celsus.
CAUSES OF TUMOR:
In common, tumours (Moscow et al.,  2011) occur when cells divide immoderately in the body.
The cell division is strictly controlled and the new cells are formed to replace existing or old
ones to perform new functions. Cells which are damaged or not needed would die for healthy
replacements. The common causes of tumour can be :
− If there is disturbance in the balance between cell division and death, a tumour may form.
− If there are problems with the body's immune system it can also lead to tumours. 
− Tobacco causes more deaths than any other environmental pollutants. Other causes are
due to:
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• Benzene, other chemicals and toxins
• Drinking too much alcohol
• Environmental toxins, such as certain poisonous mushrooms and a type of poison that can
grow on peanut plants (aflatoxins)
• Excessive sunlight exposure, genetic problems, obesity, radiation and viruses. 
Tumours which are known to be caused by viruses are:
 Cervical cancer caused by human papilloma virus
 Hepato cellular carcinoma caused by hepatitis B virus
Some tumours are more common in one gender and some are more common among children
than elderly and vice versa. Other causes are related to family history , diet, and environment.
SYMPTOMS OF TUMOUR:
Symptoms depends on the type and location of tumour. For example lung tumours may cause
shortness  of  breath,  coughing or  chest  pain and tumours  of  the colon may cause diarrhoea,
weight loss, blood in the stool, constipation or  iron deficiency anaemia.
Some tumours may not cause any symptoms until the developed stage. In certain tumours like
pancreatic cancer, symptoms do not start until the disease has reached the chronic stage. The
common symptoms of most tumours are sensation of coldness, fatigue, fever, weight loss, night
sweats and loss of appetite. 
 TYPES OF TUMOUR
Tumours are the groups of abnormal cells that forms solid masses or growths. Tumours
grow and behave differently depending on their type;  non-cancerous (benign) or cancerous
(malignant).  Precancerous conditions may have the capability to develop into a cancer.
Tumour can be classified into:
 Benign Tumour
 Premalignant Tumour
 Malignant Tumour
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Benign Tumour:
Benign tumours (Mazumdar et al., 2001) are non-cancerous and grow very slowly which
do not spread into other tissues. They are not usually life-threatening. They are not harmful
if left alone. But some benign tumours may cause problems. Most benign tumours are not
harmful to human health. But some may press against blood vessels or nerves and cause
pain  and  other  adverse  effects.  Benign  tumours  of  endocrine  tissues   results  in  the
excessive production of some hormones. Examples of benign tumors include:
• Adenomas – are tumours that arise from glandular epithelial tissue. Examples
include adrenocortical adenoma, hepatocellular adenoma, basal cell adenoma,
pituitary  adenoma,  chromophobe  adenoma,  bile  duct  adenoma,  follicular
adenoma, and nipple adenoma. Even though adenomas are non cancerous, there
is a chance of becoming cancerous, then they are called adenocarcinomas.
• Fibroids (fibromas) - benign tumors that grow on fibrous or connective tissue
of any organ in the body. Uterine fibroids are common. It is of two types-hard
fibroma,  which is  made up  of  many fibers  and  few cells;  and  soft  fibroma
which  is  made up of several  loosely connected cells  and less fibroid tissue.
Usually soft  fibroma is  found in  the armpits,  groin,  neck  and eyelids.Other
types of fibromas are angiofibroma, cystic fibroma, myxofibroma, nonossifying
and ossifying fibroma, cemento-ossifying fibroma, pleomorphic fibroma, etc.
Some fibromas  may cause  symptoms  and  require  surgical  removal.  Rarely,
fibroids that change and eventually become cancerous are called fibrosarcomas.
• Hemangiomas -  are  benign  tumors  which  consists  of  many  blood  cells.
Sometimes  they  may  be  seen  on  the  surface  of  the  skin  and  are  called
strawberry marks.  The majority of them appears at birth and they gradually
goes with time. Usually they do not require any treatment. If they affects the
patient's  sense  organs,  the  doctor  may  recommend  treatment  with
corticosteroids.  If  the  patient  is  above 10  years  of  age,  they are  commonly
removed using laser surgery.
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•  Lipomas -are soft-tissue tumors. Lipomas consist of adipose tissue (fat cells).
Most of them are very small, painless,  movable and often soft  to the touch.
They are more common among people above 40 years.  Experts disagree on
whether  lipomas  change  and  become  cancerous  (malignant).  Examples  are
angiolipoleiomyoma, angio lipoma, chondroid lipoma, intradermal spindle-cell
lipoma, neural fibrolipoma, pleomorphic lipomas and superficial subcutaneous
lipoma (most common type which is found just below the skin's surface).
Premalignant Tumor:
A premalignant (Ambrosi et al., 2002) or precancerous tumor is one that is not yet malignant or
cancerous, but is about to become so. Examples of premalignant growths include:
• Metaplasia  of  the  lung -  the  growths  occur  in  the  bronchi.  The  bronchi  which  are
grandular can change and become squamous cells. Its major cause is smoking.
• Dysplasia of the cervix - the normal cells lining the cervix of the uterus change. The
growth can be premalignant and may result in cervical cancer. Cervical dysplasia is usually
diagnosed with PAP smear. According to the National Institutes of Health, USA, about 5%
of PAP smears detect the presence of cervical dysplasia. They are common in women age
group 25 to 35. They may be removed with cryotherapy (freezing), or conization (the cone
of tissue from the cervix is removed).
• Actinic  keratosis -  also  known  as senile  keratosis or solar  keratosis,  which is  a
premalignant growth consisting of crusty, scaly and thick patches of skin. Fair people are
more susceptible to these types of growths, especially people who are exposed to sunlight.
They are potentially premalignant because a number of them progress to squamous cell
carcinoma.  There  is  about  20%  risk  that  untreated  lesions  may  eventually  become
cancerous. However continuous sun exposure increases the risk of malignancy.
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• Leukoplakia - thick, white patches on the gums, bottom of the mouth, inside cheeks and
on the tongue (less commonly). They cannot be scraped off easily. Experts believe tobacco
smoking  or  chewing  is  the  main  cause.  As  leukoplakia  is  rarely  dangerous,  a  small
percentage is premalignant and can eventually become cancerous.  Many mouth cancers
occur in the areas next to leukoplakia. 
Malignant Tumor:
Malignant  tumors (Mazumdar  et  al.,  2001)  are cancerous tumors,  they  tends  to  become
progressively worse, and can result in death. Unlike benign tumors, malignant grows fast, and
they spread  (metastasize).Metastasis  is  the  process  by which  cancer  cells  spread  from their
primary site to distant locations in the human body. For instance, a patient may have started off
with melanoma (skin cancer) which metastasized in their brain. There are many types of tumors,
which are made up of specific types of cancer cells:
• Carcinoma -  these  tumors  are  derived  from the  skin  or  tissues  that  line  body organs
(epithelial cells). For example, carcinomas can be of the lung, liver, stomach, pancreas,
colon, prostate or breast. Many of the most common tumors are of this type, especially
among the older patients.
• Sarcoma - these are tumors that start off in connective tissue, such as bones,cartilage, fat
and nerves. They originate from the mesenchymal cells outside the bone marrow. Majority
of them are malignant. They are so called after the cell, tissue or structure they originates
from,  for  instance  osteosarcoma,  angiosarcoma,  liposarcoma,  chondrosarcoma  and
fibrosarcoma.
• Lymphoma/Leukemia - cancer arises from the blood forming (hematopoietic) cells that
originate  in  the  marrow  and  generally  mature  in  the  blood  or  lymph  nodes.
Leukemia accounts  for  30% of  childhood cancers.  Leukemia is  the  only cancer  where
tumors are not formed.
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• Germ cell tumor - these are tumors that arise from germ cells or pluripotent cells. They
are most commonly present in the ovary or testicle. The majority of testicular tumors are of
germ cells. Less commonly, germ cell tumors may also appear in the brain, abdomen and
chest.
• Blastoma - tumors derived from embryonic tissue or immature precursor cells. They are
more common in children than adults. For example, medulloblastoma and glioblastoma are
kinds  of  brain  tumors,  retinoblastoma  is  a  tumor  within  the  retina  of  the  eye,  an
osteoblastoma is a type of bone tumor, while a neuroblastoma is a tumor mostly found in
children of neural origin.
Fig.1:  Stages of development of cancer
EXAMINATIONS AND TESTS FOR TUMOUR:
When a tumour is  found,  a biopsy  is  performed to  determine if  the tumour is  noncancerous
(benign) or cancerous (malignant). Depending on the location of the tumour, the biopsy can be a
simple procedure or a serious operation. Most patients with tumours have CT or MRI scans to
determine the exact location of the tumour and how far it has spread. Recently, positron emission
tomography (PET) scans have been used to find certain tumour types.
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Other tests include:
• Biopsy of the tumour
• Blood  or Urine tests 
• Bone marrow biopsy 
• Endoscopy
• Chest X-ray
• Complete blood count (CBC)
TREATMENT OF TUMOR:
Treatment varies based on:
•  The type of tumor
•  Whether it is noncancerous or cancerous
•  Its location
If the tumour is benign (meaning it has no potential to spread) and is located in a safe area where
it will not cause symptoms or affect the function of the organ, sometimes no treatment is needed.
Benign tumours of the brain may be removed because of their location or harmful effect on the
surrounding normal brain tissue.
If a tumour is cancerous, possible treatments include:
 Chemotherapy
 Surgery
 Radiation
 A combination of these methods
 Complementary and alternative medicine
If the cancer stick to one location, the goal of treatment is usually to remove the tumour with
surgery.  If  the  tumour  has  spread  only to  local  lymph  nodes,  sometimes  these  can  also  be
removed.  If  the  cancer  cannot  be  removed  with  surgery,  the  options  for  treatment  include
radiation and chemotherapy or both. Some patients need a combination of radiation, surgery, and
chemotherapy. Lymphoma is rarely treated with surgery. Radiation therapy and chemotherapy
are most often used for treating lymphoma.
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CHEMOTHERAPY
Chemotherapy (Tripathi.,  2008) is  an important  modality in cancer treatment.  Chemotherapy
involves administering powerful  chemical agents (drugs) to destroy cancer cells  in the entire
organism. It causes a greater proportion of cell death among neoplastic as opposed to normal
cells. However damage to normal cells result in chemotherapy toxicities and side effects, it can
be seen that those actively dividing cells are most vulnerable.
Antineoplastics are general category of drugs used in chemotherapy and they are classified as: 
1. Alkylating Agents :
• Nitrogen mustards -
Cyclophosphamide (Cytoxam)
Chlorambucil (Leukeran)
Melphalan (Alkeran)
Mechlorethamine hydrochloride (Mustargen)
Ifosfamide (Ifex)
• Alkyl sulphonates -
Busulphan (Myleran)
• Nitrosoureas -
Carmustine (BCNU)
Lomustine (CCNU)
• Ethylenimines -
Thiotepa
• Triazenes -
Dacarbazine (DTIC-Dome)
2. Antimetabolites
 Folate antagonist -
Methotrexate (Folex, Mexate)
 Purine analogues -
Mercaptopurine (Purinethol)
Pentostatin (Nipent)
 Pyrimidine analogues -
Cytarabine (Cytosar-U)
Fluorouracil
3. Anthracycline Antibiotics
Doxorubicin, Daunorubicin
Mithramycin, Actinomycin D
4. Vinca Alkaloids
Vinblastin (Velban)
Vincristine (Oncovin)
5. Epipodophyllotaxins
Etoposide, Teniposide
6. Taxanes
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Paclitaxel, Docetaxel
7. Camptothecins
Irinotecan, Topotecan
8. Enzymes
L-Asparaginase
9. Hormone derivatives
Tamoxifen (Nolvadex),  Prednisolone
Ethinyl estradiol
CYCLOPHOSPHAMIDE
Cyclophosphamide is a nitrogen mustard alkylating agent from oxazophorines group (McEvoy.,
2007) and it is one of the most popular anti cancer drug. It  is a medicine used to treat severe
inflammatory  illnesses  such  as  complicated  systemic  lupus  erythematosus  (SLE/lupus),
polymyositis (muscle inflammation), scleroderma and vasculitis  (inflamed blood vessels) like
Wegener’s granulomatosis. It is inactive as such; produces few acute effects, Transformation into
active metabolites (aldophosphamide, phosphoramide mustard) occurs in the liver and a wide
range of anti tumor actions is exerted.
Brand name  :    Cycloblastin, Endoxan, Cytoxan, cytophosphane
Molecular Formula    :   C7H15Cl2N2O2P
Molecular Mass           :   261.1
Mechanism of Action  :
  Cyclophosphamaide produce highly reactive carbonium ion intermediates which transfer alkyl
groups to cellular macromolecules by forming covalent bonds. Alkylation results in cross linking
or abnormal base pairing of DNA strand. Cross linking of nucleic acids with proteins can also
take place.
Side effects:
Nausea  and  vomiting,  alopecia,  Carcinogenicity,  mouth  ulcers  and  skin  rash,  bone  marrow
depression,  bladder  inflammation,  Infections,  neurotoxicity  and  reduce  fertility,  Easy
bruising/bleeding,  joint  pain,  mouth  sores,  syndrome  of  inappropriate  antidiuretic  hormone
(SIADH), unusual decrease in the amount of urine and unusual tiredness or weakness.
Dosage :
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Cyclophosphamide (Novack et al., 1971) can be taken by mouth as tablets or it can be given via
a vein as an infusion or injection. For long-term treatment it is normally taken in tablet form. For
adults and children, usual dose is 1 to 5mg/Kg body wt/day.
Uses :
Cyclophosphamide is used in the treatment of  Hodgkin & Non-Hodgkin lymphoma, Multiple
myeloma, Leukaemia, cutaneous T-cell lymphoma, neuroblastoma, retinoblastoma, cancer of the
ovary and breast, small cell cancer of the lung and sarcoma and also immune diseases.
PREVENTION OF TUMOUR:
The risk of cancerous (malignant) tumours can be reduced by:
• Eating a healthy diet
• Exercising regularly
• Limiting alcohol
• Maintaining a healthy weight
• Minimizing the exposure to radiation and toxic chemicals
• Not smoking or chewing tobacco
• Reducing sun exposure, especially if you burn easily
TUMOUR MARKERS :
These are glycoproteins in the blood that  can be detected by monoclonal  antibodies.  Highly
elevated levels of a tumour marker (Sturgeon et al., 2009) will provide helpful information but
improper use can have economic significance, cause patients additional anxiety and strain, and
unessential investigations may be associated with side-effects and may delay correct diagnosis
and treatment.
Uses
Each tumour marker has a variable profile of uses (Perkins et al., 2003)
 Screening - Screening tests require high sensitivity to detect early stage disease. 
 Disease staging - For diagnosis and prognosis.
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 Monitoring for cancer recurrence - When monitoring these patients, tumour marker
levels should be determined only when there is a potential for meaningful treatment.
 Assessing response to therapy
• Tumour marker values returning to normal may indicate cure contempt radiographic
evidence of continous disease. In  this circumstance,  the residual  tumour is often
non-viable.
• However  an  increase  in  tumour  marker  levels,  associated  with  lack  of  clinical
improvement, may indicate treatment failure.
• Residual elevation after specific treatment usually indicates persistent disease.
                                         Tab.1: Clinically important Tumor markers
SL.NO: TUMOR MARKER ASSOCIATED PRIMARY TUMOR
1 CA 27.29 Breast cancer
2 CEA Colorectal cancer
3 CA 19-9 Pancreatic and biliary tract cancers
4 AFP
Hepatocellular carcinoma, Nonseminomatous 
germ cell tumors
5 b-hCG
Non-seminomatous germ cell tumors and 
Gestational trophoblastic disease
6 CA-125 Ovarian cancer
ROLE OF MEDICINAL PLANTS IN CHEMOTHERAPY
India is the largest producer of medicinal plants and is called the Botanical garden of the World.
Medical information in the old Indian literatures includes several medicinal  plants which are
used for thousands of years under the indigenous system of medicine. About 45,000 plant species
have  been  identified  in  India,  out  of  which  about  15,000 to  20,000  plants  are  having good
medicinal value. However, among these plants, traditional communities use only about 7000-
7500 plants for medicinal purposes. The Ayurvedic system of medicine uses about 700, Siddha
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600, Unani 700 and the modern medicine uses about 30 medicinal plants for treating a variety of
diseases in both man and animal. Only few medicinal plants are attracted by the scientists for
investigating them as a remedy for tumour. More than 50% of all modern drugs in clinical use are
of  natural  products.  Many of  them have  been  recognized  to  have  the  capability  to  include
apoptosis  in  various  tumour  cells.  According  to  the  World  Health  Organization  (WHO)
estimates, more than 80% of the people in developing countries depend on traditional medicine
for their primary health needs.  Some medicinal plants and their vegetables, fruits and crops play
an important role in cancer prevention. Consumption of huge amount of fruits and vegetables can
prevent the development of cancer. Doctors recommends that people who likes to reduce their
risk  of cancer should eat  several  pieces of  fruits  and vegetables  daily.  Several  plant-derived
products exhibit potent antitumor activity against many cancer cell lines. 
A good number of medicinal plants (Khare., 2007) are found mentioned in the ancient classical
Ayurvedic texts 'Charaka Samhita', 'Astanga Hridaya Samhita' and 'Susruta Samhita'. But many
of them are still to be properly identified. 
Anticancer properties of plant derived or natural products:
Plants have a long history of use in the treatment of cancer. Hartwell, in his review of plants used
against cancer (Cragg et al., 2005) lists more than 3000 plant species that have reportedly been
used in the treatment of cancer. It is significant that over 60% of currently used anticancer agents
are derived in one way or another from natural sources including plants.
Plant derived compounds have played an important role in the development of several clinically
useful anticancer agents. Many of the anticancer agents including taxol, vinblastine, vincristine
and  topotecan  are  in  clinical  use  all  over  the  world. Vinblastine  and  vincristine  from  the
Madagascar  periwinkle, Catharanthus  roseus (Apocynaceae),  introduced  a  new era  in  using
plant material as a medication for treatment. They were the first agents in clinical use for the
treatment  of  cancer.  Vincristine  and  Vinblastine  are  used  in  combination  with  other  cancer
drugs,as the treatment for various kinds of cancers, including breast and lung cancers, leukemias,
lymphomas,  advanced  testicular  cancer. A number  of  hopeful  agents  such  as  combrestatin,
betulinic acid and silvesterol are in clinical or preclinical development. 
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Medicinal plants (Kaur et al., 2011) maintain the health and vitality of individual and also cure
various diseases including cancer without toxicity. Natural products which are discovered from
medicinal plants have played an important role in treatment of cancer. These plants possess good
antioxidant and immunomodulatry properties leading to anticancer activity.
 Since chemotherapy and radiation cause severe toxicity,  herbal  plants are becoming popular
throughout  the  world  nowadays,  and  are  also  used  as  a  therapy for  tumors  or  cancer.  The
antitumour (antineoplastic) activities of several medicinal plants (Sharma et al., 2009) have been
reported by various authors. Many of these plants include: 
 Abrus precatorious 
 Aglaia roxburghiana
 Cassia fistula 
 Catharanthus roseus
 Crocus sativus 
 Ervatamia heyneana 
 Hygrophila spinosa 
 Hippocratea murcantha 
 Indigofera mysorensis 
 Ocimum sanctum 
 Olea polygama 
 Plumbago rosea
 Podophyllum hexandrum
 Semecarpus anacardium
 Solanum dulcamara
 Terminalia arjuna
 Trigonella foenumgraecum
 Vanda parviflora
 Wedelia calendulacea
 Withania somnifera
 Zingiber capitatum .
In the present study Gmelina arborea stem bark is used. It is a medicinal plant, belonging to the
family  Verbeneceae.  The  present  study  is  aimed  at  the  anti  inflammatory  and  anti  tumour
potential of the plant  Gmelina arborea. Experimental evidence indicates its anti inflammatory
and  anti  tumour  potential.  Since  inflammation  is  involved  in  cancer  this  may  have  better
possibility to act as anti tumour agent. The present study is under taken to evaluate its effect on
inflammation inducing agents and tumour cell lines in mice. 
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REVIEW OF LITERATURE
Many of the herbal medicines and their active ingredients have been identified as the potential
modifiers  of  cancer  (Sawadogo  et  al 2012).  Herbal  medicines  are  yielding  important
breakthroughs  in  the  treatment  and  prevention  of  cancer  and  have  been  used  first  line  in
numerous  cultures  across  the  world  (Kraft.,  2009).  Research  indicates  the  various  possible
mechanisms of action of herbal medicines, and their biological components, which act alone to
reduce cancer risk through their anti-oxidant (Shahin., 2008), anti-carcinogenic properties and
their direct suppressive effect on carcinogen bioactivities. Medicinal plants have been used for
healing and preventative health for thousands of years all around the world. Herbal medicines
may be used prophylactically, symptomatically and accurately. 
Treatment with herbal medicine is considered as the second method to fight cancer utilized by
cancer patient in developed countries (Kennedy., 2005 and Ezeome., 2007). It is considered as
first line in the developing countries because of their availability and the affordable cost. Many
plants  were  well  known  for  anticancer  property  such  as  Nigella  sativa  (black  seed),
Cinnamomum  cassia  (Cinnamon),  Panax  ginseng  (Ginseng),  Camellia  sinensis  (Green  tea),
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Allium  sativum  (garlic),  Zingiber  officinale  (Ginger).  Several  experiments  and  case  report
studies  have  been  done  and  most  of  the  conducted  studies  also  showed  supportive  results.
Moreover, various clinical trials have been conducted for several herbal products (Gonzalez  et
al., 2010). 
Most of Cancer diseases (90%) are due to external factors, only 10% is due to genetic factors
(Peto., 2001).   Preventive medicine will be very effective in fighting cancer and reducing the
prognoses. The herbal products are most suitable since they have traditional and experimental
evidences from other alternative medicines.  The herbal medicines only requires studies to be
conducted to use as preventive medicines. Modern technolology can help us to conduct these
studies because there are animals which can carry human genes and long epidemiological studies
can be carried out.
Anti-Cancer Agents Derived from Plants in Clinical Use
3.1. Vinca Alkaloids
The  first  agents  introduced  in  clinical  use  were  vinca  alkaloids  such  as  vinblastine  and
vincristine,  isolated  from  the Catharanthus  roseus  (Apocynaceae).  These  drugs  were  found
during an investigation for the oral hypoglycemic agents. The plant was endemic to Madagascar,
and samples used in the discovery of vincristine and vinblastin were collected in Philippines and
Jamaica.  Recently semi-synthetic analogues of vinca alkaloids are vinorelbine and vindesine.
These are used alone or in combination with other chemotherapeutic agents to fight a variety of
cancers.  Vinblastine is  used for the treatment of breast cancer,  testicular cancer,  lymphomas,
leukemias,  lung cancers  and Kaposi’s  sarcoma.  Vincristine had also showed efficacy against
leukemia and acute lymphocytic leukemia. Of over 2069 anti-cancer clinical trials recorded by
the National Cancer Institute, over 160 are the combinations of drugs with these agents against a
range of cancers.
3.2. Podophyllotoxin Derivatives
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The species of Podophyllaceae family such as Podophyllum peltatum Linn., P. emodii Wallich
have been reported with a history of therapeutical use. Extensive research studies in the 1960s
and 1970s led to the development of etoposide and teniposide as clinical agents which are being
used  in  the  treatment  of  bronchial  and  testicular  cancers.  Of  2069 anti-cancer  clinical  trials
recorded by the National Cancer Institute, over 150 are drug combinations with etoposide against
a range of cancers.                                  
3.3. Taxanes
A recent  advancement  in  the  development  of  plant  derived  chemotherapeutic  agents  is  the
development of a class called Taxanes. Paclitaxel also named as taxol was first isolated from the
bark of Taxus brevifolia Nutt. (Taxaceae). Paclitaxel is used in the treatment of variety of cancers
including ovarian, breast cancer and non-small-cell lung cancer, and also shown efficacy against
Kaposi sarcoma. Docetaxel is a semisynthetic derivative which is used in the treatment of breast
cancer. Of 2069 cancer clinical trials recorded by the National Cancer Institute, 248 are listed as
involving  taxane-derived  drugs,  including  134  with  paclitaxel  (Taxol),  105  with  docetaxel
(Taxotere), and 10 with miscellaneous taxanes, either as single agents or in combination with
other anti-cancer drugs. 
3.4. Campothecin Derivatives
Another  advancement  that  was made in  the anti-cancer  drug is  the  class  of  clinically-active
agents  derived  from Camptothecin.  Campothecin  was  isolated  from the  Chinese  ornamental
tree, Camptotheca acuminate  (Nyssaceae), and known as the tree of joy in china. The extract
of C.  acuminata was  the  only one  out  of  1000  various  plant  extracts  tested  for  anti-cancer
activity  which  showed  safety  and  efficacy,  and  the  active  constituents  was  identified  as
Camptothecin. The derivatives are Topotecan  and Irinotecan. Topotecan is used for the treatment
of ovarian and small-cell lung cancers and Irinotecan is used for colorectal cancer treatment. Of
the  2069  cancer  clinical  trials  recorded  by  the  National  Cancer  Institute,  94  are  listed  as
involving camptothecin-derived drugs, including 64 with irinotecan (CPT-11), 26 with topotecan,
and 4 with other miscellaneous analogues as single agents or in combination with other anti-
cancer drugs and 15 other camptothecin derivatives are in preclinical development.
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3.5. Homoharringtonine
Other plant-dericed agents which are in clinical use are Homoharringtonine. Homoharringtonine
was isolated from the Chinese tree  Cephalotaxus harringtonia (Cephalotaxaceae).  Elliptinium
was first isolated from species of the Apocynaceae family including Bleekeria vitensis, a Fijian
medicinal plant with anti-cancer properties. In China, a racemic mixture of harringtonine and
homoharringtonine  (HHT)  is  being  used  successfully  in  acute  and  chronic  myelogenous
leukemia.  Purified  homoharringtonine  is  effective  against  certain  leukemias  and  has  been
reported to produce complete hematologic abrogation in patients with late chronic phase chronic
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myelogenous leukemia. Elliptinium is used in France for the treatment of breast cancer and is
marketed (Om Prakash et al., 2013).
                                                  Tab.2 : Plant-derived anticancer agents
Sl.no: Compound Source Mechanism Cancer Use
1
 
Vincristine Catharanthus roseus mitotic block  
Lymphoma, Leukemia, 
breast, lung cancers
2 Vinblastine Catharanthus roseus mitotic block  Breast, lymphoma
3 Paclitaxel
Taxus brevifolia
Nutt,  Taxus baccata Anti-mitotic Ovary, lung, breast, 
bladder
4 Docetaxel
Taxus brevifolia
Nutt,  Taxus baccata Anti-mitotic Breast and lung cancer
5 Topotecan Camptotheca 
acuminate
DNA 
topoisomerase I 
inhibition  
Ovarian, lung and 
pediatric cancer
6 Irinotecan Camptotheca 
acuminate
DNA 
topoisomerase I 
inhibition  
Colorectal and lung 
cancer
7 Flavopiridol  
Amoora rohituka & 
Dysoxylum 
binectariferum
Inhibits cell cycle 
progression at G1 
or G2 phase  
colorectal, lung and 
renal cell carcinoma, 
non-Hodgkin’s 
lymphoma, leukemia, 
solid tumors
8 Ellipticine  Ochrosia borbonica, Excavatia coccinea, 
Ochrosia elliptica
DNA intercalation 
and inhibition of 
topoisomerase II
Various cancer cell 
types
9
Etoposide and 
Teniposide
Podophyllum 
peltatum and 
Podophyllum emodi  not known
Lymphomas, bronchial
and testicular cancers
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GENERAL ADVERSE EFFECTS OF  EXISTING ANTI CANCER DRUGS
Since most anticancer drugs act on the rapidly multiplying cells, they are also toxic to the normal
multiplying cells in the bone marrow, epithelial cells of skin and mucous membranes lymphoid 
organs and gonads. Thus the common adverse effects are:
• Bone marrow depression resulting in leucopenia, thrombocytopenia and aplastic anaemia.
• Stomatitis, oesophagitis, glossitis and proctitis.
• Alopecia
• Depression of the immune system resulting in fatal infections such as typhilis.
• Infertility
• Teratogenicity
• Hyperuricemia- Rapid tumour cell lysis can result in an increased plasma uric acid levels
and may precipitate gout.
• Carcinogenicity- Cytotoxic drugs themselves may cause secondary cancers
• Neurological adverse effects
• Immediate adverse effects like nausea and vomiting.
• Fatigue
• Cause bleeding by killing the rapidly dividing blood cells  that  reduce the number of
platelets in the blood.
STUDIES OF PHYTOCHEMICALS RELATED TO CANCER DRUG DEVELOPMENT
The first agents to advance into clinical use were the vinca alkaloids, vinblastine (VLB) and
vincristine  (VCR) isolated  from the  Catharanthus  roseus (Apocynaceae).  This  was  used  by
various  cultures  of  diabetes  .  While  under  the  investigation  as  a  source  of  potential  oral
hypoglycemic agents it was noted that extract reduced white blood cell counts and it caused bone
marrow depression in rats and was found to be active against lymphocytic Leukemia in mice.
This led to the isolation of VLB and VCR as active agents.
Podophyllum  species  (Podophyllaceae),  Podophyllum  pelltatum  Linnaeus  and  Podophyllum
emodii  Wallich from the Indian sub continent had medical use including the treatment of skin
cancers and warts (Lee et al., 2005).
Another important addition to the anti  cancer armamentarium is the class of clinically active
agents  derived  from  Camptothecin  which  is  isolated  from  the  Chinese  ornamental  tree
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Camptotheca acuminate.  The two derivatives obtained from this are Topotecan and Irinotecan.
Topotecan is used for the treatment of ovarian and small cell lung cancers while Irinotecan is
used for the treatment of colorectal cancern (Rahier et al ., 2005).
In  yet  another  antitumor study,  foccused on flavanoids,  polyphenolic  compounds the role  of
dietary flavanoids in cancer prevention were widely discussed. Comparing data from laboratory
studies, human clinical trials and epidemiological investigations, indicated that flavanoids have
important effects on cancer chemoprevention and chemotherapy. Many  different mechanisms of
action  was  identified,  including  carcinogen  inactivation,  cell  cycle  arrest,  anti  proliferation,
induction of apoptosis and differentiation, inhibition of angiogenesis, antioxidation and reversal
of multi drug resistance or a combination of these mechanisms (Ren et al., 2003).
Plant derived anti inflammatory agents :
Many hundreds of plants contain well known for their anti-inflammatory activities. Many herbs
also shows anti-inflammatory (also known as antiphlogistic) characteristics. In toxicity studies,
the anti-inflammatory plants shows great safety. Hundreds of plants contain well known anti-
inflammatory effects. For example, Hops, an herb used in beer brewing, consists of a group of
compounds  called  the  humulones,  which  are  being  studied  for  their  effective  pain-relieving
properties. It  is sad when drugs that are commonly used are shown to pose great dangers to
health.  This  is  contradictory to  their  purpose.  But  the  plant-based  medicines  is  significantly
advanced and now we have products available to us which will reduce or eliminate pain without
being harmful to health. This is a good thing. As a result of the inherent problems associated with
the current anti-inflammatory agents there is continous search from natural sources for possible
agents. A wide variety of plants are employed in the treatment of inflammatory disorders by
natural healers. 
Some of these plants include 
o Aloe vera 
o Consolida regali 
o Chasmanthera dependens
R.V.S College Of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 28 
Study of in vitro cytotoxicity and in vivo anti- tumour and anti-inflammatory activities of
Gmelina arborea Roxb. stem bark
o Culcasia scandens
o Crataeva religiosa
o Tanacetum vulgare
o Holmskioldia sanguine
o Mitracarpus scaber
o Turner ulmifolia
o Zingiber officinale
o Curcuma longa
o Azhadirachta indica
o Withania somnifera
                  Most of these plants have shown varying activities in the various in vivo and in
vitro inflammatory models. The potency of these plants belongs to several active principles
present in them, which may act at any of the targets in the inflammatory response pathway.
Besides anti-inflammatory activity, some of these plants also hold beneficial properties such
as analgesic, antipyretic and antiulcer and antimicrobial effects,. These effects enhance the
inherent anti-inflammatory activity and may grant advantage on these plants. Some active
anti-inflammatory constituents of these plants have been identified and isolated. They include
–  lupeol,  premnazole,  (+)  –  usnic  acid,(+)  –pinitol,  zanhasaponins  A and  B,  sasanquol,
parthenolide etc. These compounds could provide drugs with comparative advantage over
existing agents..In  addition,  these medicinal  plants will  continue to serve as reservoir for
development of potent drugs with less serious and life-threatening adverse effects (Okoli et
al., 2002).
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                                  OBJECTIVES
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 Preparation of methanolic extract and its fractions of Gmelina arborea stem and bark.
 Invitro  cytotoxicity  assay  of   Gmelina  arborea  extract  using  Trypan  blue  exclusion
method.
 Analysis of anti inflammatory activity of Gmelina arborea  extract using dextran induced
and formalin induced acute and chronic inflammations.
 Analysis  of  In  vivo antitumor activity of  Gmelina arborea extract  in  mice using DLA
induced solid tumor and EAC induced ascites tumuor model.
                                               
                 
                           Plan of work
The plan of work for the study of Gmelina arborea was carried out as follows:-
Pharmacognosy studies:
 Collection of plant parts
 Authentication of plant materials.
 Successively solvent extraction by using Soxhlet apparatus.
 Preliminary phyto chemical screening.
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Pharmacological studies:
 In vitro cytotoxic assay using DLA, EAC cell lines by Trypan blue exclusion method
 In vivo anti inflammatory activity of plant extract by
     a) Dextran induced acute inflammation
     b) Formalin induced chronic inflammation
 In vivo anti tumour activity of plant extract by
a) DLA induced solid tumor model in mice
b) EAC induced ascites tumour model in mice
.
       1.  PLANT  PROFILE
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Fig 2: Photograph of Gmelina arborea plant 
TAXONOMICAL CLASSIFICATION       
Table: 3 – Taxonomical classification of G.arborea
Kingdom Plantae
Division Magnoliophyta
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Class Magnoliopsida
Sub class Asteridae
Order Lamiales
Family Verbenaceae
Genus Gmelina
Species G. arborea
VERNACULAR NAMES
Table : 4 – Vernicular names of G.arborea
Assamese Gomari
Bengali Gamari, Gambar
Hindi Gamhar, Khamara.
Kannada Kooli mara,Shivane mara, Kumbuda
Malayalam Kumbil, Kumbulu
Marathi Shivan, Siwan
Sanskrit Gambhari, Sindhuparni
Tamil Kumla, Kumalamaram
Telugu Gumartek, Gummadi, Summadi
BOTANICAL DESCRIPTION
Gmelina arborea is a fast growing tree, which grows on different localities and prefers
moist fertile valleys with 750–4500 mm rainfall. It does not thrive on ill-drained soils and
remains stunted on dry, sandy or poor soils; drought also reduces it to a shrubby form.
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The Gmelina arborea tree attains moderate to large height up to 30 m and its wood is
pale  yellow  to  cream coloured  or  plukish-buff  when  fresh,  turning  yellowish  brown  on
exposure and is  soft  to  moderately hard,  light  to moderately heavy,  lustrous when fresh,
usually straight to irregular or rarely wavy grained and medium course textured.
Leaves are large, tomentose underneath, cordate-ovate, acuminate.
Flowering takes place during February to April when the tree is more or less leafless
whereas fruiting starts from May onwards up to June. 
The fruit is up to 2.5 cm long, smooth, dark green, turning yellow when ripe and has a
fruity smell.
DISTRIBUTION
In India, Gmelina  arborea occurs  extensively  from  the Ravi eastwards  in  the  sub-
Himalayan tracts, common throughout Assam and adjoining areas of northern West Bengal,
also  in  southern Bihar and Odisha,  sporadically found  in  western  and  southern  India  and
planted elsewhere on a large scale. Gamhar most commonly occurs in West Bengal forests in
mixed forests. It also occurs naturally in Myanmar, Thailand, Laos, Cambodia,Vietnam and
in southern provinces of China.
MAJOR CHEMICAL CONSTITUENTS 
Lignans, such as 6“ - bromo –isoarboreol, 4-hydroxysesamin, 4,8-dihydroxysesamin, 1,4-
dihydroxysesamin  (gummadiol),  2-piperonyl-3-hydroxymethyl-4-(α-hydroxy-3,4-
methylenedioxybenzyl)-4-hydroxytetrahydrofuran and the 4-O-glucoside of 4-epigummadiol,
can be isolated from the heartwood of Gmelina arborea (A S R Anjaneyulu et al.,1977). The
parent compounds are arboreol or  gmelanone( A S R Anjaneyulu et al., 1975). 
Presence  of  Umbelliferone  7-apiosylglucosidecan  on  the  root  is  reported  (P
Satyanarayana et al., 1985). Other constituents present in plant are β-sitosterol, ceryl alcohol,
gmelinol; butyric acid & tartaric acids; apigenin, premnazole, arborone, isoarboreol, cutytyl
ferulate,  epieudesmin,  gmelanore,  gmelafuran,  gummadiol,  saponifiable  fraction,  apiosyl-
skimmin, octacosanol etc.
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TRADITIONAL USES 
The  bark  of  Gmelina  arborea are  stomachic,  galactogogue,  laxative  and  antihelmenthic,
improve appetite, useful in hallucination, piles, abdominal pains, burning sensations, fever,
‘Tridosha’ and urinary discharge. It is also recommended with other drugs for the treatment
of snake bite and scorpion sting.
• Leaf paste is applied to relieve headache and juice is used as wash for ulcers. Gamhar
leaves, Apamarga roots and bark skin of Saimali are mashed with cow’s milk and are
given orally to treat hyperacidity. The leaves juice, milk and sugar are recommended in
inflammatory condition of urinary bladder and dysuria.
• Flowers are sweet, cooling, bitter, acrid and astringent which is useful  in leprosy and
blood diseases.
• Fruit is acrid, sour, bitter, sweet, cooling, diueretic, tonic, aphrodisiac, promote growth of
hairs, useful in ‘Vata’, thirst, anaemia, leprosy, ulcers and vaginal discharge. It  is also
recommended  in  raktapitta,  excessive  thirst,  sexual  debility  in  males  and  habitual
abortion. The ripened fruit is valuable in heart disease of vata imbalance.
• The roots are described in the ayurvedic tests as mild laxatives which treats flatulence
and increase appetite, lactation and reliever of menstrual irregularities. The cold infusion
of candana, ustra and menstrual gamhar works well with sugar to alleviate the thirst. It is
also usefull in piles, burning sensation, fever and ‘Tridosha’.
IMPORTANT PREPARATIONS
Dasamularishta,  Sriparni  taila;  Draksadi  Kvatha,  Kasmaryadi  panaka,  Kasmarya
rasayana, Kasmarya taila.
     
 PHARMACOLOGICAL STUDIES
1.  In a study, the cytotoxicity of ethanolic leaf extracts of Gmelina arborea (Verbenaceae) was
tested against Colon cancer (COLO 201), Gastric cancer (HT-29) and Human oesophagel
cancer (TE-2) cell lines using the thiazolyl blue test (MTT) assay. Ethanolic leaf extracts of
G. arborea was exhibited a prominent inhibitory effect against COLO 201 (IC 50- 20±0.15
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mg/ml),  HT-29 (IC  50-12±0.32 mg/ml)  and TE-2 (IC  50-  16±0.05mg/ml)  under  in  vitro
condition. From the results it could be found that G. arborea ethanolic leaf extract has potent
in vitro cytotoxic activity (David Punitha et al 2012).
2. In a study the anti-inflammatory and anti-nociceptive properties of aqueous extracts (AE) and
methanol  extracts  (ME)  of  G.  arborea was  evaluated.  Anti-inflammatory  activity  was
determined in Wistar albino rats in acute inflammation model induced by carrageenan. And
anti-nociceptive activity was evaluated by using hot plate test  and writhing test  in Swiss
albino mice. The findings suggested that  G. arborea possess significant anti-inflammatory
and anti-nociceptive activities (Yogesh et al 2013).
3.  The effect of Gmelina arborea bark and fruit aqueous extracts on paraquat- and hydrogen
peroxide–induced oxidative stress was investigated using liver slice culture. Both paraquat
and  hydrogen  peroxide  were  found  to  be  cytotoxic  as  measured  by  release  of  lactate
dehydrogenase from liver slice culture. Addition of bark and fruit extracts along with these
cytotoxic agents led to a decrease in lactate dehydrogenase release. Addition of the plant
extracts  along with  the  pro-oxidants  suppressed  the  enzyme activities.  The  extracts  also
displayed  antioxidant  activity in  in  vitro  radical  scavenging assays.  Results  indicate  that
Gmelina bark and fruit  extracts protected liver slice culture cells by alleviating oxidative
stress induced damage to liver cells (Sangeetha et al 2006).
4. In  a  study,  the  immunomodulatory  effects  of  roots  of Gmelina  arborea Linn.  were
investigated. Methanolic extract of G. arborea Linn. (MEGA) and its ethyl acetate fraction
(EAFME) were used and the modulating effect was evaluated on humoral and cell-mediated
immune response using animal models like cyclophosphamide-induced myelosuppression,
delayed-type hypersensitivity (DTH) response, and humoral antibody (HA) titre. Both test
extracts produced significant increase in HA titre, DTH response, and levels of total white
blood cell count and the drug was found to be a potential immunostimulant (Shukla  et al
2010).
5. In another study the analgesic activity of different extracts of fruits of Gmelina arborea using
ethanol, ethyl acetate and n-butanol as solvents  were evaluated. The analgesic activity was
determined by tail immersion and acetic acid induced writhing response method using Swiss
albino  mice  as  animal  model.  The  extracts  were  found  as  non-toxic.  The  ethanol  and
petroleum ether extracts showed significant analgesic activity as compared to standard drugs
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Pentazocine  and  Indomethacine.  It  could  be  concluded  that  G.  arborea  fruits  possess
analgesic activity (Bhabani et al 2014).
MATERIALS
I. COLLECTION OF PLANT MATERIAL
Plant material:-
Binomial       : Gmelina arborea
Family  : Verbenaceae
R.V.S College Of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 38 
Study of in vitro cytotoxicity and in vivo anti- tumour and anti-inflammatory activities of
Gmelina arborea Roxb. stem bark
Common name     : Gamhar
Habit : Tree
Parts used : Stem Bark
Collection:- The stem bark of Gmelina arborea (GA) was collected from and authentified by the 
Department of Botany. The plant material was dried at 45-50ºC for one week and powdered. 
II. ANIMALS
Male Swiss Albino mice (6 to 8 weeks old) weighing 25-30g was used for the present study. The
animals were housed in well ventilated polypropylene cages under controlled temperature (22-
250C), relative humidity (60-80%) and light-dark cycle of 12 hrs. They were provided with mice
feed and water  ad libitum.  All  the  animal  experiments  were  carried  out  in  RVS College  of
Pharmaceutical Sciences, according to the rules and regulations of Institutional Animal Ethics
Committee (IAEC).
III. CELL LINES
Dalton’s  lymphoma  ascites  tumor  cells  (DLA)  and  Ehrlich  ascites  carcinoma  cells  (EAC)
maintained in Amala Cancer Research Centre were used for the assay. 
Maintaining of tumor cell lines:-
Dalton’s Lymphoma Ascites (DLA) and Ehrlich’s Ascites Carcinoma (EAC) cells were
maintained in the ascites fluid of the peritoneal cavity of mouse. The aspirated tumor cells were
washed  3  times  with  PBS  (pH-7.4)  and  adjusted  the  cell  count  to  1×106 cells/ml  using
haemocytometer.  Approximately, 1×106 cells were injected intraperitonially to develop ascites
tumor in mice.
METHODS
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1. PREPARATION OF EXTRACT
The  powdered  plant  material  was  extracted  with  70%  methanol  using  a  Soxhlet  extraction
system. The extract was filtered and evaporated to dryness. The colour, and the % yield of the
extract were noted. The dried extract was re-dissolved in distilled water and used for further
studies.
2. EVALUATION OF ANTI-INFLAMMATORY ACTIVITIES
2.1. DEXTRAN INDUCED ACUTE INFLAMMATION
Male Swiss Albino mice (25-30) were divided into 4 groups of 7 animals each.
Group 1 – Control – 1% dextran alone
Group 2 -  Standard  -10mg/Kg Diclofenac + 1% Dextran
Group 3 -  GALC - GA low dose (250mg/Kg body. wt) + 1% Dextran
Group 4 -  GAHC - GA high dose (500mg/Kg body .wt) + 1% Dextran
The animals were pretreated with respective drug doses for 3 days. On the 4th day exactly 1hr
after administration of GA extract or Diclofenac, all the animals were injected subplantarly into
right hind paw with 0.02 ml of 1% suspension of Dextran in 0.1% carboxy methyl cellulose to
induce  inflammation.  Paw  volume  was  measured  1hr  prior  and  for  5hr  after  Dextran
administration using vernier caliper. The percentage of inhibition was calculated according to the
following formula 
% inhibition   = [(VT –V0)Control - (VT –V0)] treated group (VT –V0)* 100
Where,  VT  =  Paw oedema at various time intervals; V0  =  initial paw oedema
2.2. FORMALIN  INDUCED CHRONIC INFLAMMATION
Male Swiss Albino mice (25-30) were divided into 4 groups of 7 animals each.
Group 1 – Control – 1% Formalin alone
Group 2 -  Standard  -10mg/Kg Diclofenac + 1% Formalin
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Group 3-  GALC - GA low dose (250mg/Kg body. wt)+ 1% Formalin
Group 4-  GAHC - GA high dose (500mg/Kg body .wt)+ 1% Formalin
All the animals were injected subplantarly into right hind paw with 0.02 ml of 1% suspension of
Formalin.  The  animals  were  treated  with   respective  doses  of  GA extract  /  standard  drug
Diclofenac one hour prior to formalin injection and continued for next 6 days. The paw volume
was measured 1hr prior and for 6 days after formalin administration.
% inhibition   = [(VT –V0)Control - (VT –V0)] treated group (VT –V0)* 100
Where,  VT  =  Paw oedema at various time intervals; V0  =  initial paw oedema
3. IN VITRO CYTOTOXICITY ANALYSIS:-
Determination of short term in vitro cytotoxicity of Gmelina arborea stem bark extract by trypan
blue dye exclusion method.
Principle:-
Viable cells exclude the dye while non-viable cells take up the dye and will appear in
blue color under magnification by a microscope.
Materials required:-
Dalton’s lymphoma ascites cells and Ehrlich ascites carcinoma cells maintained in Amala
Cancer Research Centre, phosphate buffer saline (PBS pH 7.4), trypan blue and Hemocytometer.
Preparation of Phosphate Buffer Saline (PBS):-
NaCl                         -  4g
KCl - 0.1g
Na2HPO4.2H2O - 0.72g
KH2PO4 - 0.1g
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Distilled water - 500ml
pH - 7.4
Procedure:-
Short-term  cytotoxicity  activity  of  the  G.arborea methanol  extract  was  assayed  by
determining the percentage viability of DLA and EAC cells using the trypan blue dye exclusion
technique (Moldeus et al, 1978). DLA and EAC cells were cultured in the peritoneal cavity of
healthy albino mice  weighing  between  25 to  30g by injecting  a  suspension  of  cells  (1×106
cells/ml), intraperitonially. Tumor cells were aspirated aseptically from the peritoneal cavity of
tumor bearing mice on day 15, washed with PBS for 3 times and cells were suspended in 1ml
PBS (0.1ml cells +0.9ml) and adjusted the cell number to 1×106 cells/ml. The viability of the
cells was checked using trypan blue stain (0.1ml cells+ 0.9ml PBS+ 0.1ml trypan blue) with
Hemocytometer. The cells were incubated at 370C for 3 hours with different concentration of
drug with 1×106 tumor cells. After incubation, 0.1ml trypan blue were added to determine the
number of dead cells using Hemocytometer and substituting in the equation:
Percentage of identity of cytotoxicity = Number of dead cells
   X   100
Number of total cells
4. IN VIVO ANTI-TUMOR ANALYSIS
For assessing the antitumor activity,  Dalton’s  Lymphoma Ascites  (DLA) cell  induced
solid tumor model and Ehrlich Ascites Carcinoma (EAC) cell induced ascites tumor model were
employed.
4.1. EAC INDUCED ASCITES TUMOR MODEL SYSTEM:-
Male Swiss Albino mice were grouped into four groups (6 animals per each group). 
Group I: Control – Untreated; 
Group II: Standard – Cyclophosphamide 10mg/kg; 
Group IV: GALC – GA extract low concentration (250 mg/kg b.wt);
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 Group V: GAHC - GA extract high concentration (500 mg/kg b.wt).
EAC cells were aspirated from peritoneal cavity of the tumor bearing mice and 0.1ml
containing  1x106 cells/ml  was  injected  intraperitoneally  into  all  the  animals.  The  drug
administration has started next day after the induction of tumor and continued for 10 consecutive
days. The animals were observed for the development of ascites tumor and death due to tumor
burden was recorded for 30 consecutive days. The life span of animals was calculated using the
formula,
%ILS = (T-C)/C × 100, where T and C are mean survival of treated and control mice
respectively (Mazumdar UK, 1997).
4.2. DLA INDUCED SOLID TUMOUR MODEL SYSTEM:
4.2.1. Assessment of tumor volume:
Male Swiss Albino mice were grouped into four groups (6 animals per each group). 
Group I: Control – Untreated; 
Group II: Standard – Cyclophosphamide 10mg/kg; 
Group IV: GALC – GA extract low concentration (250 mg/kg b.wt);
 Group V: GAHC - GA extract high concentration (500 mg/kg b.wt).
DLA cells were aspirated from peritoneal cavity of the tumor bearing mice and 0.1ml
containing 1x106 cells/ml was injected intramuscularly into the right hind limb of all the animals.
The drug administration was started next day after the induction of tumor and continued for 10
consecutive  days.  The  tumor  development  on  animal  in  each  group  was  determined  by
measuring the diameter of the tumor growth in two perpendicular planes using a vernier caliper
at fixed intervals (on each 3rd day) and the volume was calculated using the formula,
Tumor volume = 4/3 pi r12×r2where r1is the minor radius and r2 is the major radius.
And the percentage of inhibition of tumor volume in animals was calculated by,
% of inhibition  =[(tumor volume of control  on 30th day – Tumor volume of treated
on30th)/(Tumor volume of control on 30th day)] × 100
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4.2.2. Comparison of haematological parameters between cyclophosphamide treated and
G. arborea  treated animals
As part  of the DLA induced solid tumor model study,  the haematological  parameters of the
animals were tracked on every 3rd day. For this, blood was collected from the caudal vein into
heparinised tubes and total WBC count and haemoglobin level were checked.
4.2.2.1. Determination of total WBC count:-
Principle:
The whole blood was diluted using a diluent which haemolyses red cells, leaving all the
nucleated cells intact. The number of white cells in a known volume and known dilution were
counted using a counting chamber.
Preparation of Diluting Fluid
Glacial acetic acid - 2ml
1% crystal violet (1g in 100ml) - 1ml
Distilled water - 97ml
Stir overnight, filter and store.
Procedure:
0.02 ml of blood was added to 0.38 ml of diluting fluid and mixed well. The diluted
blood was charged into a Neubauer counting chamber. After 3-4 min, the total number of white
blood cells in the four large corner square chambers was counted. 
Calculation:
Total WBC = (Number of cells counted x 50) / mm3
4.2.2.2. Determination of haemoglobin (Hb) content:- Cyanmethaemoglobin method
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Principle:-
Haemoglobin was treated with a reagent containing potassium ferricyanide, potassium
cyanide and potassium dihydrogen phosphate. The ferricyanide forms methaemoglobin, which is
converted to cyanmethaemoglobin by cyanide. The intensity of colour formed is measured at 546
nm against blank. The optical  density is  directly proportional  to the amount of haemoglobin
present in blood. 
Requirements:- Kit manufactured from Agappe Diagnostics
Procedure:-
0.02 ml of fresh whole blood was mixed with 5 ml of the cyanmeth reagent. The optical
density was measured at 546 nm against blank after 5 min incubation at room temperature. The
OD of standard solution corresponding to 60 mg/dl haemoglobin at 546 nm was also read against
reagent blank.
Calculation:-
Haemoglobin (g/dL) = (OD of treated x 60 x 0.251) / OD of standard
STATISTICAL ANALYSIS
The values were expressed as mean±SD. Statistical evaluation of the data was done
by one way ANOVA followed by Dunnett‘t’ test using graph pad instat 3 software. Results were
considered statistically significant when p<0.05.
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RESULTS
1. Extraction of Gmelina arborea stem bark
The stem bark of G. arborea were extracted using 70% methanol and the yield was 9.5% W/W
(Tab.5).
Tab. 5 :  Characteristics of Gmelina arborea stem bark extract
Name of Extract Colour Consistency Yield (% W/W)
70% Methanolic Extract Black Sticky 9.5
2. In vivo Anti inflammatory analysis
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2.1. Dextran induced acute inflammation
          The Gmelina arborea high dose (GAHC) group significantly reduced the paw thickness by
34.14% in the 3rd hour when compared to the control group. GALC dose group reduced the paw
edema by 15.36%.  The percentage  inhibition  in  standard  (Diclofenac,  10mg/Kg)  group  was
21.34% (Tab.6 & Fig. 3). 
Tab.6: In vivo anti-inflammatory effect of G. arborea stem bark extract on Dextran induced
acute inflammation.
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Groups Initial Pawthickness (cm)
Paw thickness on 3rd
hour (cm)
Increase
in paw
thickness
(cm)
% of
inhibition
Control 0.253±0.019 0.417±0.0091 0.164
Standar
d 0.253±0.015 0.3826±0.0162c
0.129267
21.34146
GALC 0.2445±0.0152 0.383±0.0178c 0.138833 15.36585
GAHC 0.24725±0.023 0.3558±0.019c 0.108583 34.14634
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Fig.3: In vivo anti-inflammatory effect of G. arborea stem bark extract on Dextran induced
acute inflammation. Values are expressed as mean ± SD for 6 animals
2.2. Formalin induced Chronic inflammation
        The percentage inhibition of paw edema was 18.5% for Gmelina arborea low dose treated
group and 34.07% in  Gmelina arborea  high dose treated group. The percentage inhibition in
standard group was 45.92% (Tab. 7 & Fig. 4).
Tab.7 : In vivo anti-inflammatory effect of  G. arborea stem bark extract on Formalin
induced chronic inflammation.
Groups Initial Paw
thickness (cm)
Paw thickness on
6th day (cm)
Increase
in paw
thicknes
s (cm)
% of
inhibitio
n
Control 0.268±0.0098 0.403±0.0139 0.135
Standar
d 0.2644±0.0115 0.3383±0.0108c 0.073933 45.92
GALC 0.2656±0.013 0.376±0.0146c 0.110333 18.51
GAHC 0.2723±0.0106 0.3615±0.0119c 0.089167 34.07
Values are expressed as mean ± SD for 6 animals: c: - p<0.01
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Fig. 4:  In vivo anti-inflammatory effect of  G. arborea  stem bark extract on Formalin
induced chronic inflammation. Values are expressed as mean ± SD for 6 animals
Fig. 5: Animal models for Dextran induced acute inflammation and Formalin induced
chronic inflammation.
A: - Dextran induced acute inflammation; B: - Formalin induced chronic inflammation
3.  In vitro Cytotoxic Analysis
3.1.   Cytotoxic effect of Gmelina arborea on DLA cell lines
The methanol extract of  Gmelina arborea  stem bark showed marked cytotoxic activity
against DLA cell lines, in a dose dependent manner (Fig. 6). The concentration required for 50%
death (IC50) was found to be 729.02µg/ml for DLA cells.
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Fig. 6: In vitro cytotoxic effect of G. arborea stem bark extract on DLA cell lines. Values are
expressed as mean ± SD for 4 experiments.
3.2.  Cytotoxic effect of Gmelina arborea on EAC cell lines
The methanol extract of Gmelina arborea caused considerable mortality of EAC cells in
the in vitro cytotoxicity assay, following the trypan blue exclusion method (Fig. 7). Incubation
with increased concentrations of the extract produced a relational increase in cell death. The IC50
value was determined to be 849.49 µg/ml for EAC cells.  
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Fig. 7: In vitro cytotoxic effect of G.arborea stem bark extract on EAC cell lines. Values are
expressed as mean ± SD for 4 experiments.
4.   In vivo Antitumor analysis
4.1.    Effect of  Gmelina arborea  extract on average life span in ascites tumor induced
models.
The animals of the tumor control group inoculated with EAC cells survived for a period
of 19.28± 1.79 days. The animals treated with cyclophosphamide survived for 27.42± 0.97days.
The  Gmelina  arborea  methanolic  extract  at  250  and  500  mg/kg  body weight  increased  the
average life span of animals by 22.14± 1.06 days and 24.5± 1.64 days respectively. Both were
significantly high (p<0.01), in comparison with the control. The  Gmelina arborea  methanolic
extract at 500 mg/kg body weight was found to be more inhibiting the proliferation of EAC cells
with the percentage increase in life span by 27.04 % than the GALC extract (14.81 %). However,
in cyclophosphamide treated mice (10 mg/kg), the percentage increase in life span was found to
be the highest (42.22 %) (Tab. 8 & Fig. 8).
Tab.8:  Effect  of  Gmelina  arborea stem  bark  treatment  on  average  life  span  of  ascites
tumour bearing mice.
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Groups
Mean survival
days % ILS
Control 19.28±1.79
Standard 27.42±0.97c 42.22
GALC 22.14±1.06c 14.81
GAHC 24.5±1.64c 27.04
Values are expressed as mean ± SD for 6 animals: c: - p<0.01, when compared to control.
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Fig.8: Effect of Gmelina arborea stem bark treatment on average life span of ascites tumour
bearing mice. Values are expressed as mean ± SD for 6 animals; c:- p<0.01 when compared to
control.
4.2.     Effect of  Gmelina arborea  methanolic extract on tumor volume in solid tumor
induced models.
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4.2.1. Assessment of tumour volume
The animals injected with DLA cell lines alone showed marked increase in tumor volume on the
30th day of inoculation in control group. The tumor volume in the mice treated with GA extract at
dosages  of  500  mg/kg  b.wt  and  250  mg/kg  b.wt.  on  the  30th day of  inoculation  decreased
significantly by 49.78 % and 65.54 % respectively. The tumor volume had decreased by 74.83 %
in cyclophosphamide (10mg/kg) treated group (Tab. 9 & Fig. 9).
  Tab.9: Effect of Gmelina arborea stem bark treatment on average solid tumour volume
Groups
Tumor volume on
30 th day (cm3) % Inhibition
Control 1.639±0.125
Standard 0.412±.006c 74.83151
GALC 0.823±0.085c 49.78437
GAHC 0.564±0.025c 65.54948
Values are expressed as mean ± SD for 6 animals: c: - p<0.01 when compared to control.
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       Fig. 9: Effect of Gmelina arborea stem bark treatment on average solid tumour volume.
Values are expressed as mean ± SD for 6 animals:
4.2.2.  Comparison  of  haematological  parameters  in  cyclophosphamide  and  Gmelina
arborea treated tumor models.
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4.2.2.1.  Total WBC count:- 
Fig. 10 & Tab. 10 shows that cyclophosphamide treatment led to a decline in the total
WBC count over the period of study, which is also believed to be one of the contra indications of
its use.  But such reduction of leukocyte count was not observed in  Gmelina arborea treated
animals,  as  evident  from the count  taken  on the 30th day.  Cyclophosphamide  administration
brought down the values to 12400 ± 557.73cells/mm3, towards the end of the study, which was
significantly very low (p<0.01), as compared to the control p<0.05, GALC p>0.05 and GAHC
p>0.05 groups. 
              
Fig. 10:  Effect of  Gmelina arborea stem bark treatment on total WBC count. Values are
expressed as mean ± SD for 6 animals: a: - p<0.01 and ns: - non significant, when compared to
standard.
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Tab.10: Effect of Gmelina arborea stem bark treatment on total WBC count.
Days
0 5 10 15 20 25
20534.3±453.4ns 21416.67±708.59a 21233.33±605.50a 22143±552.75a 21600±1052.75a 22716.67±673.20a 22166.67±608.16
19965.4±567.5 19900±401.3 16966.67±731.5 15885±541.66 14416.67±777.2 13350±824.57 12400±557.73
20105.2±342.7ns 14480±945.12a 17200±635.16a 17460.45±554.57a 18300±841.75a 22400±564.57a 21540±551.66
19938.7±334.2ns 20200±334.14ns 20616.67±434a 21045.62±632.75a 21466.67±422.7a 20283.33±651.66a 21300±657.06
Values are expressed as mean ± SD for 6 animals: a: - p<0.01 and ns: - non significant, when
compared to standard
4.2.2.2.   Haemoglobin content:- 
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Though  it  was  evident  that  animals  treated  with  cyclophosphamide  (10  mg/kg b.wt)
exhibited  substantial  anti-  tumour  activity  in  solid  tumour  induced  mice  models,  there  was
marked reduction in the haemoglobin content of their blood estimated on the 30th day (9.86 ±
0.259 g/dl) (Fig.11 & Tab. 11). This was significantly different from the control (12.23 ± 0.255
g/dl), GALC (13.21 ± 0.489 g/dl) and GAHC groups (13.80 ± 0.194 g/dl) (p<0.01). As seen from
Fig. 11,  the cyclophosphamide treated group alone showed a sharp decrease in haemoglobin
levels over a time period of 30 days. Treatment with G. arborea stem bark extract didn’t show
such reduction in Hb, besides being mediation in reducing solid tumour volume. 
Fig.11: Effect of  Gmelina arborea stem bark treatment on haemoglobin levels. Values are
expressed as mean ± SD for 6 animals: a: - p<0.01 and ns: - non significant, when compared to
standard.
Tab.11: Effect of Gmelina arborea stem bark treatment on haemoglobin levels.
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Treated
Groups
Days
0 5 10 15 20 25 30
Control 12.67±0.132ns 12.408±0.112a 12.565±0.29a 12.63±0.313a 12.398±0.235a 11.930±0.098a 12.23±0.255a
Standar
d 13.04±0.238ns 10.554±0.112a 10.254±0.426a 10.543±0.328a 10.164±0.641a 10.069±0.432a 9.86±0.259a
GALC 13.26±0.248ns 13.61±0.435a 13.573±0.528a 13.489±0.654a 13.420±0.278a 13.226±0.118a 13.217±0.489a
GAHC 13.10±0.385ns 13.034±0.598a 12.946±0.485a 13.453±0.739a 13.879±0.213a 13.770±0.411a 13.804±0.194a
Values are expressed as mean ± SD for 6 animals: a: - p<0.01 and ns: - non significant, when
compared to standard
Fig. 12:  Animal models for DLA induced solid tumor and EAC induced ascites tumor.
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A: - EAC induced ascites tumor model, B:- DLA induced solid tumor model.
                                                       
DISCUSSION
Medicinal plants and their phytochemicals, are reported to possess substantial antioxidant, anti-
inflammatory anticarcinogenic activities. These phytochemicals have been explored extensively
for  their  potential  in  the  treatment  of  cancer.  Well  known  compounds  like  paclitaxel,  a
diterpinoid from Taxus brevifolia, and vincristine, an alkaloid from Catharanthus roseus (Wall et
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al., 1996), semisynthetic derivatives (Topotecan and Irinotecan) of alkaloid camptotecan from
Camptotheca accuminata (Rahier et al., 2005) are used in chemotherapy today.
In  this study methanolic extract of  Gmelina arborea  is  evaluated for its  anti cancer and anti
inflammatory activity. Gmelina arborea Roxb (Verbenaceae) is a well-known medicinal plant in
Ayurveda, an ancient Indian system of medicine. The roots, leaves, flowers, fruits and bark are
used  for  treating  different  disorders  in  traditional  medicine.  There  are  reports  on
phytoconstituents present in different  parts of the plant. The isolation of luteolin (Rao  et al.,
1969) and  indole  alkaloids (Bhattacharjee  et  al.,  1969) from  the  leaves  has  been  reported.
Hentriacontanol (Joshi  et  al., 1971) and lignans such as arboreol, isoarboreol, methyl arboreol,
arborone, gmelanone, gummadiol, and 7-oxodihydrogmelinol (Govindachari  et al.,  1972) have
been isolated from heartwood of the plant. Few coumarin glycosides (Satyanarayana et al., 1985)
and iridoid glycosides (Hosny et al., 1998) have been reported in roots and leaves, respectively.
Three  iridoid  glycosides  6-O-(3"-O-benzoyl)-α-L-rhamnopyranosylcatalpol,  6-O-(3"-O-trans-
cinnamoyl)-α-L-rhamnopyranosylcatalpol  and  6-O-(3"-O-cis-cinnamoyl)-α  L
rhamnopyranosylcatalpol  were isolated from aerial  parts  of  G. arborea (Tiwari  et  al.,  2008).
A study  reported  the  presence  of  apigenin  in  the  bark  (Vidya  et  al.,  2011), tyrosol  [2-(4-
hydroxyphenyl)  ethanol];  (+)-balanophonin,  an  8-5′ neolignan,  gmelinol,  phenylethanoid
glycoside  {(−)-p-hydroxyphenylethyl  [5"′-O-(3,4  dimethoxycinnamoyl)-b-D-apiofuranosyl
(1"' → 6')]-b-D-glucopyranoside}, 2,6-dimethoxy-p-benzoquinone and 3, 4, 5-trimethoxyphenol
(Syamsul et al., 2008). 
On the basis of the results obtained from the study, it is concluded that a methanolic extract of
Gmelina arborea stem bark, which contains large amounts of phenolic compounds, exhibits high
antioxidant activities. The in vitro assays indicates that this plant extract is a significant source of
natural  antioxidant,  which  might  be  helpful  in  preventing the  progress  of  various  oxidative
stresses (Patil  et al., 2009). Since the plant possesses antioxidant activity  it may enhance the
anticancer effects without causing side effects when compared to chemotherapeutic agents.
      Inflammation is a part of the complex biological responses of vascular tissues to harmful
stimuli such as irritants, damaged cells, or pathogens (Ferrero-Miliani et al., 2007). Inflammation
can  be  classified  as acute or chronic.  Acute  inflammation is  initial  response  of  the  body  to
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harmful stimuli and is brought by the increased movement of leukocytes and  plasma from the
blood  into  the  injured  tissues.  A  series  of  biochemical  events  are  propagated  and  the
inflammatory response matures, involving the immune system, local vascular system and various
cells  within  the injured tissue.  The common signs  of  acute inflammation are pain,  swelling,
redness,  heat,  and  loss  of  function.  Prolonged  inflammation  which  is  known  as chronic
inflammation, leads to a progressive shift in the type of cells present at the site of inflammation
and is characterized by simultaneous destruction and healing of the tissue from the inflammatory
process.
 The association between inflammation and cancer was illustrated by clinical studies (Balkwill et
al.,  2001 and Coussens  et  al.,  2002).  For  instance,  the risk of colorectal  cancer was 10-fold
greater if linked with inflammatory bowel disease, such as Crohn's disease and  ulcerative colitis
(Tzkowitz et  al.,  2004).  Moreover,  the  control  of  colitis  by certain  anti-inflammatory agent
reduced colon cancer incidence (Moody et al., 1996). It was also suggested that cancer risk is
positively associated with the severity and duration of inflammatory diseases (Keeley  et  al.,
1997).  The cause of inflammation may be microbial  infection or a non infective physical  or
chemical irritant (Philip  et al., 2004). Chronic inflammation not caused by infection may also
lead to carcinogenesis and the risk of esophageal  cancer,  pancreatic cancer,  and gall  bladder
cancer  may  be  increased  by  inflammatory  diseases  such  as  chronic  pancreatitis,  Barrett's
metaplasia and esophagitis, (Macarthur et al., 2004 and Whitcomb, 2004). Possible associations
were also found in Marjolin's  ulcer  and skin carcinoma,  asbestos  and mesothelioma ,  silica,
cigarette smoke, and bronchial cancer (Macarthur et al., 2004), chronic asthma and lung cancer
(Vesterinen et  al.,  1993  and  Wu  et  al.,  1995),  sarcoidosis  and  lung,  skin,  and  liver  cancer
(Askling  et al.,  1999), ulcerative lichen planus and verrucous carcinoma (Carlson et al., 1998
and Mayrom et al.,  1998), foreskin inflammation and penile cancer (Perky., 1977), and pelvic
inflammatory disease or ovarian epithelial inflammation and ovarian cancer (Risch et al., 1995).
Chronic prostatitis, resulting from either persistent bacteria infection or noninfective stimuli, was
associated with prostate cancer (Palapattu  et al., 2004). Therefore, there is increasing evidence
that supports the association between chronic inflammation and cancer development.
The present study establishes the anti inflammatory and anti tumour activity of Gmelina arborea
stem bark extract in animal models. Formalin and Dextran induced paw edema as an  in vivo
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model of inflammation was frequently used to assess the effect of anti inflammatory activity of
natural products.  The clinical treatment of inflammatory diseases is dependent on non-steroidal
or  steroidal  chemical  therapeutics  (Rainsford,  2007).  However,  long  term  administration  of
NSAID may induce gastrio-intestinal  ulcers,  bleeding and renal  disorders  (Robert,  1976 and
Tapiero et al., 2002) and also the use of steroidal anti-inflammatory agents causes multiple side
effects (Schacke  et al., 2002 and Reinke  et al., 2002). Therefore, developing new agents with
more powerful anti-inflammatory activities with lesser side effects will be of great interest.
Dextran induced paw edema is a consequence of liberation of histamine and serotonin from mast
cells while formalin induced paw edema is mediated by an early release of bradykinin followed
by release of histamine, 5-hydroxytryptamine (5-HT) and prostaglandins (Wheeler et al., 1991).
The involvement  of  bradykinin  and some other  inflammatory mediators  in  formalin-induced
edema and plasma extravasation was examined. Various mediators are released in the paw and
the release of the substances like cytokinin, histamine and serotonin results in enhanced vascular
permeability and thereby promotes the accumulation of fluid in the tissues that accounts for the
edema.  In the present study, the dextran model showed reduction in paw edema (P< 0.01) with
the administration of extract at doses of 250 and 500 mg/Kg b. wt. The results suggest that the
extract may have an inhibitory effect on these mediators. 
Formalin  induced  paw  edema  is  one  of  the  most  suitable  test  procedure  to  screen  anti-
inflammatory agents. In  G. arborea extract treated groups of animals a decrease in paw edema
(P< 0.01) is found which revealed the protective activity of the extract in chroninc inflammatory
condition. Anti inflammatory activity of various plant extracts has also been reported (Perez et
al., 1995).
The anti cancer activity of  G. arborea  extract was also studied by in vitro  cytotoxicity and  in
vivo animal models using two mouse cancer cell lines DLA and EAC. Since cancer is one of the
major cause of death worldwide and the failure of conventional chemotherapy to effect a major
reduction in mortality indicates that new approaches are critically needed (Balasubramanian et
al., 2007). Plants possess various biological activities including anti inflammatory, anti oxidant
and anti cancer activities (Lee et al., 2004). Some studies have reported that extracts from natural
products such as fruits, vegetables and medicinal herbs have positive effects against cancer when
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compared with chemotherapy or recent hormonal treatments (Pezzuto., 1997). Therefore many
plants have been examined to identify new and effective antioxidant and anti cancer compounds
as well as to elucidate the mechanisms of cancer prevention (Kim et al., 1998). 
The results obtained from the cytotoxicity assay by trypan blue dye exclusion method indicates
that the methanol extract of Gmelina arborea could inhibit the growth of DLA and EAC cells via
exhibiting cytotoxic effect.  Cytotoxicity is  one of  the  chemotherapeutic  targets  of  antitumor
activity (Suffness et al., 1991). The cytotoxic activity of Gmelina arborea against DLA and EAC
cell lines partially explains its significant anti tumor activity against solid and ascites tumor. The
antitumor activity was evaluated in solid tumor model. Methanolic extract of Gmelina arborea
reduced the tumor burden effectively. 
The oral administration of the G.arborea extract at 250 and 500 mg/kg body weight for 30 days
in  mice  considerably  reduce  DLA induced  solid  tumour  volume  by  49.78  %  and  65.54  %
respectively. The total WBC count and hemoglobin level in the  G.arborea treated animals are
similar to that of normal untreated mice. However, the standard drug, Cyclophosphamide shows
significant  reduction  in  total  WBC  count,  and  haemoglobin  level.  This  result  is  very
encouraging, as today majority of the tumour reducing drugs specifically show drug induced
myelosuppression and other complications. Even though the standard drug, cyclophosphamide,
used shows marked decrease in the tumor burden, it forms several side effects which may lead to
the cause of death. In the present study, extract of G. arborea stem bark does not produce such
lethal effects. In this state, we use phytochemicals as a remedy for surviving cancer without or
with fewer side effects.  They may not be as effective as standard drug, but are less toxic to
normal  cells  and  do  not  cause  side  effects.  This  seems  to  be  advantageous  over  other
chemotherapeutic drugs which impart side effects.
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                                                            CONCLUSION
In this study the methanolic extract of the plant Gmelina arborea stem bark was evaluated for its
anti inflammatory and anti tumour property. The anti inflammatory study was done in dextran
and formalin induced inflammatory models, whereas the anti tumour activity was screened in
solid and ascites tumour model in mice. The results clearly suggest that methanolic extract of
Gmelina arborea possess significant anti inflammatory and anti cancer activity. The extract also
showed  in vitro  cytotoxic effect  on DLA and EAC cell  lines.  Further studies are required to
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confirm the exact  mechanism underlining anti  inflammatory and anti  cancer  property of  the
extract and to identify the chemical constituents responsible for it.
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